Can ketorolac be administered to an elderly patient with a serum creatinine of 45 µmol/L?

No, ketorolac should not be given to this elderly patient with a creatinine of 45 µmol/L

While a serum creatinine of 45 µmol/L appears normal and suggests preserved renal function (normal range 55-90 µmol/L for women, 70-115 µmol/L for men), serum creatinine alone is an unreliable marker of kidney function in elderly patients and significantly underestimates renal impairment in this population.

Why Serum Creatinine Misleads in the Elderly

In elderly patients, serum creatinine commonly remains within normal laboratory ranges despite significant underlying renal dysfunction due to:

• Reduced muscle mass (creatinine is produced from muscle catabolism)
• Decreased exercise and meat intake
• Age-related decline in GFR (approximately 8 mL/min per decade after age 40)

1 Studies demonstrate that among patients with "normal" serum creatinine measurements, one in five actually has asymptomatic renal insufficiency when properly assessed. Serum creatinine can underestimate renal insufficiency by misclassifying kidney disease stage in >30% of elderly patients 2.

Required Assessment Before Any NSAID Use

Before considering ketorolac, you must calculate the estimated glomerular filtration rate (eGFR) using the CKD-EPI equation (recommended for adults of any age) 2. The Cockcroft-Gault equation is also acceptable but less accurate in elderly patients.

Do not prescribe ketorolac based on serum creatinine alone 1.

Ketorolac-Specific Contraindications and Cautions

Absolute Contraindications (FDA Label):

• Advanced renal impairment (serum creatinine concentrations indicating significant dysfunction) 3
• Patients at risk for renal failure due to volume depletion 3

High-Risk Elderly Considerations:

The 2019 AGS Beers Criteria recommend avoiding NSAIDs in elderly patients with creatinine clearance <30 mL/min (moderate evidence) 4. The revised Beers criteria specifically identify NSAIDs as potentially inappropriate medications requiring caution in reduced renal function.

The "triple whammy" combination of NSAIDs + diuretics + ACE inhibitors/ARBs more than doubles AKI risk 5. If your patient takes any two of these medications, adding ketorolac creates this dangerous combination.

Ketorolac Pharmacokinetics in Renal Impairment

In patients with renal disease:

• Mean half-life extends from 5-6 hours to 6-19 hours (depending on impairment severity)
• AUC increases by approximately 100% for each enantiomer
• Volume of distribution doubles for the S-enantiomer
• Poor correlation exists between creatinine clearance and ketorolac clearance in elderly populations (r = 0.5) 3

Ketorolac and its metabolites are eliminated primarily by the kidneys (92% of dose in urine), making reduced renal function particularly problematic 3.

Clinical Evidence on Safety

The evidence on ketorolac safety in elderly patients is mixed but concerning:

• A 2026 retrospective study found perioperative ketorolac (primarily single 30 mg IV dose) was not associated with increased postoperative AKI in elderly surgical patients 6
• A 2020 ED study showed single-dose parenteral ketorolac in select geriatric patients (≥65 years) did not increase adverse cardiovascular, GI, or renal outcomes 7
• However, a 1997 study demonstrated that ketorolac therapy >5 days doubled the risk of acute renal failure compared to opioids (adjusted rate ratio 2.08,95% CI 1.08-4.00) 8

The Critical Issue: Unknown True Renal Function

Your fundamental problem is that you cannot determine this patient's actual renal function from the serum creatinine value of 45 µmol/L alone. This value could represent:

• Normal renal function in a young, muscular individual
• Moderate-to-severe renal impairment (CrCl 30-59 mL/min or worse) in an elderly patient with low muscle mass

Recommended Approach

1. Calculate eGFR using CKD-EPI equation (requires age, sex, race, serum creatinine) 2

2. If eGFR ≥60 mL/min/1.73m²: Ketorolac may be considered with extreme caution

   • Use reduced dosing per FDA recommendations for elderly 3
   • Limit duration to ≤5 days 8
   • Monitor renal function closely 3
   • Avoid if patient takes diuretics + ACE-I/ARB 5

3. If eGFR 30-59 mL/min/1.73m² (Stage 3 CKD): Ketorolac should be avoided per Beers Criteria 4

4. If eGFR <30 mL/min/1.73m²: Ketorolac is contraindicated 3

5. If unable to calculate eGFR: Do not prescribe ketorolac—choose alternative analgesics (acetaminophen, opioids with appropriate precautions)

Key Pitfalls to Avoid

• Never rely on serum creatinine alone in elderly patients 1
• Recognize that "normal" lab values don't equal normal function in the elderly 2
• Remember that elderly patients are more sensitive to dose-related NSAID adverse effects and require reduced dosing even with normal renal function 3
• Avoid prolonged therapy (>5 days increases renal failure risk significantly) 8